Revolution Medicines officer plans $484K sale

RVMD officer Anthony Mancini filed a Rule 144 notice for a planned sale of 2,377 common shares tied to RSU vesting.

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) was named as the issuer in a notice that officer Anthony Mancini intends to sell common stock under Rule 144. The notice covers a planned sale of 2,377 shares of common stock, with an aggregate market value of $484,361.29, with an approximate sale date of September 15, 2026.

The securities are to be sold through E*TRADE Financial Corporation, and the filing notes that 214,336,418 shares of RVMD common stock were outstanding. The shares to be sold relate to RSU vesting and are stated as being for services rendered. The form also lists prior common stock sales by Mancini during the previous three months.

Key Figures

Shares to be sold: 2,377 shares Aggregate market value of planned sale: $484,361.29 Shares outstanding: 214,336,418 shares +4 more

7 metrics

Shares to be sold 2,377 shares Planned Rule 144 sale of RVMD common stock around September 15, 2026

Aggregate market value of planned sale $484,361.29 Planned sale of 2,377 RVMD common shares under Rule 144

Shares outstanding 214,336,418 shares RVMD common stock outstanding referenced in the notice

Shares sold September 10, 2026 15,448 shares Past 3 months RVMD common stock sale by Anthony Mancini

Aggregate amount September 10, 2026 sale $3,153,806.67 Sale of 15,448 RVMD shares on September 10, 2026

Shares sold June 16, 2026 4,615 shares Past 3 months RVMD common stock sale by Anthony Mancini

Aggregate amount June 16, 2026 sale $720,490.11 Sale of 4,615 RVMD shares on June 16, 2026

Key Terms

Rule 144, aggregate market value, RSU vesting, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Common Stock ... 2,377 ... 484361.29 ..."

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

RSU vesting financial

"Common Stock | 09/15/2026 | RSU vesting | Issuer"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

attorney-in-fact regulatory

"Signature | Jack Anders, as Attorney-in-fact for Anthony Mancini"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for RVMD disclose about planned sales?

The notice states that officer Anthony Mancini plans to sell 2,377 shares of Revolution Medicines common stock under Rule 144, with an aggregate market value of $484,361.29 and an approximate sale date of September 15, 2026, in connection with RSU vesting for services rendered.

How many RVMD shares are outstanding according to this Form 144?

The filing states that there are 214,336,418 shares of Revolution Medicines, Inc. common stock outstanding, providing context for the planned Rule 144 sale amount.

Which broker is involved in the planned RVMD share sale under Rule 144?

The planned sale of 2,377 shares of Revolution Medicines common stock is to be executed through E*TRADE Financial Corporation, identified with its Alpharetta, Georgia office address in the filing.

What RVMD stock sales has Anthony Mancini made in the past three months?

The notice lists prior sales of RVMD common stock by Anthony Mancini of 15,448 shares on September 10, 2026 for an aggregate amount of $3,153,806.67, and 4,615 shares on June 16, 2026 for an aggregate amount of $720,490.11.

What is the source of the RVMD shares to be sold under this Form 144?

The Form 144 indicates that the 2,377 shares of Revolution Medicines common stock to be sold on or about September 15, 2026 arise from RSU vesting and are described as being for services rendered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 06:10 PM Accepted by SEC EDGAR 09/15/2026 - 06:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002124509
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	650-481-6801
Name of Person for Whose Account the Securities are To Be Sold	Mancini Anthony
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	2377	484361.29	214336418	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/15/2026	RSU vesting	Issuer			2377	09/15/2026	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Anthony Mancini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	09/10/2026	15448	3153806.67
Anthony Mancini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	06/16/2026	4615	720490.11

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jack Anders, as Attorney-in-fact for Anthony Mancini
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)